Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yan Qin MD"'
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Objective: Human endogenous retrovirus-H long terminal repeat associating 2 (HHLA2) is a new immune checkpoint in the B7 family, and the value of HHLA2 in small cell lung cancer (SCLC) is unknown. Methods: We retrospectively detected HHLA2 expression
Externí odkaz:
https://doaj.org/article/9c2a96ad6f314d518e303b24718522f6
Autor:
Yi Jiang MD, Fang-fang Liu MD, Yu-qing Cai MD, Peng Zhang MM, Xiao-feng Yang MM, Xiang-yan Bi MM, Ruo-yan Qin MD, Shi Zhang MM, Ju-hua Yin MM, Li-ping Shen MD, Jia-xiang Liu BMed, Ling-shuang Liu MM
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Objective: Powerful adjuvant strategies are required to improve the survival of patients with completely resected stage ΙΙΙA non-small cell lung cancer (NSCLC). We aimed to compare the efficacy of traditional Chinese medicine (TCM) treatment versu
Externí odkaz:
https://doaj.org/article/2975a9d95f3e4347b2a1a1a6f32f5fde
Publikováno v:
Current Therapeutic Research, Vol 101, Iss , Pp 100753- (2024)
ABSTRACT: Ustekinumab is a first-line drug for Crohn's disease. However, little is known about its potential adverse effects on renal function. We present the case of a 42-year-old man with Crohn's disease who developed chronic renal dysfunction duri
Externí odkaz:
https://doaj.org/article/5bcd1853395d456eacc010f90b515c0a